CYTK
Price
$62.10
Change
-$1.92 (-3.00%)
Updated
May 10, 6:59 PM EST
81 days until earnings call
DSGN
Price
$4.57
Change
-$0.20 (-4.19%)
Updated
May 10, 6:59 PM EST
85 days until earnings call
Ad is loading...

CYTK vs DSGN

Header iconCYTK vs DSGN Comparison
Open Charts CYTK vs DSGNBanner chart's image
Cytokinetics
Price$62.10
Change-$1.92 (-3.00%)
Volume$714.21K
CapitalizationN/A
Design Therapeutics
Price$4.57
Change-$0.20 (-4.19%)
Volume$152.02K
CapitalizationN/A
View a ticker or compare two or three
CYTK vs DSGN Comparison Chart

Loading...

CYTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DSGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CYTK vs. DSGN commentary
May 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and DSGN is a Hold.

COMPARISON
Comparison
May 13, 2024
Stock price -- (CYTK: $62.10 vs. DSGN: $4.57)
Brand notoriety: CYTK and DSGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 72% vs. DSGN: 72%
Market capitalization -- CYTK: $6.51B vs. DSGN: $258.18M
CYTK [@Biotechnology] is valued at $6.51B. DSGN’s [@Biotechnology] market capitalization is $258.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $568.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 2 FA rating(s) are green whileDSGN’s FA Score has 0 green FA rating(s).

  • CYTK’s FA Score: 2 green, 3 red.
  • DSGN’s FA Score: 0 green, 5 red.
According to our system of comparison, CYTK is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 3 TA indicator(s) are bullish while DSGN’s TA Score has 5 bullish TA indicator(s).

  • CYTK’s TA Score: 3 bullish, 6 bearish.
  • DSGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а -4.86% price change this week, while DSGN (@Biotechnology) price change was +22.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.77%. For the same industry, the average monthly price growth was -5.00%, and the average quarterly price growth was +67.78%.

Reported Earning Dates

CYTK is expected to report earnings on Aug 01, 2024.

DSGN is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Biotechnology (-1.77% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CYTK with price predictions.
OPEN
A.I.dvisor published
a Summary for DSGN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CYTK($6.51B) has a higher market cap than DSGN($258M). DSGN YTD gains are higher at: 72.453 vs. CYTK (-25.620).
CYTKDSGNCYTK / DSGN
Capitalization6.51B258M2,524%
EBITDAN/AN/A-
Gain YTD-25.62072.453-35%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CYTK: Fundamental Ratings
CYTK
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
26
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYTKDSGN
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
66%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
85%
Bullish Trend 10 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
CYTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DSGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BUFQ28.530.11
+0.39%
FT Vest Laddered Nasdaq Buffer ETF
TEQI39.670.08
+0.20%
T. Rowe Price Equity Income ETF
ISEP27.400.05
+0.20%
Innovator Intl Dev Pwr Bffr ETF - Sept
RHTX14.960.01
+0.07%
RH Tactical Outlook ETF
FPE17.230.01
+0.06%
First Trust Preferred Sec & Inc ETF

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with TVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then TVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-3.00%
TVTX - CYTK
57%
Loosely correlated
-4.55%
VBIV - CYTK
44%
Loosely correlated
+2.77%
KRON - CYTK
43%
Loosely correlated
-2.86%
IOVA - CYTK
42%
Loosely correlated
-18.48%
DARE - CYTK
42%
Loosely correlated
-0.99%
More

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been closely correlated with GLTO. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if DSGN jumps, then GLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-4.19%
GLTO - DSGN
79%
Closely correlated
-2.90%
TCRT - DSGN
54%
Loosely correlated
-6.77%
CYTK - DSGN
39%
Loosely correlated
-3.00%
COGT - DSGN
39%
Loosely correlated
-4.55%
MDGL - DSGN
38%
Loosely correlated
-0.81%
More